Shih-Sung Chuang Selected Research

T-Cell Intracellular Antigen-1

4/2011	Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
10/2003	Anaplastic large cell lymphoma--a rare disorder in southern Taiwan.
1/2002	Primary bony peripheral T-cell lymphoma mimicking nasal type NK/T-cell lymphoma: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shih-Sung Chuang Research Topics

Disease

29	Neoplasms (Cancer) 08/2022 - 01/2002
20	Lymphoma (Lymphomas) 11/2020 - 01/2002
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2020 - 02/2006
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 08/2005
7	B-Cell Lymphoma (Lymphoma, B Cell) 03/2020 - 11/2009
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 08/2006
4	Multiple Myeloma 08/2022 - 11/2002
4	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2018 - 01/2003
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 02/2016
3	Plasmacytoma 03/2020 - 11/2002
3	Leukemia 01/2018 - 03/2012
3	Necrosis 10/2012 - 01/2002
2	Plasmablastic Lymphoma 08/2022 - 03/2020
2	Extranodal NK-T-Cell Lymphoma 12/2018 - 01/2018
2	Septic Shock (Toxic Shock Syndrome) 02/2013 - 03/2007
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2012 - 01/2009
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2012 - 07/2009
2	Lymphadenopathy 01/2010 - 01/2008
2	Inflammation (Inflammations) 12/2007 - 03/2007
1	Genomic Instability 01/2022
1	Celiac Disease (Celiac Sprue) 01/2022
1	Enteropathy-Associated T-Cell Lymphoma 01/2022
1	Primary Effusion Lymphoma 03/2020
1	Subcutaneous panniculitis-like T-cell lymphoma 02/2016
1	Primary Cutaneous Anaplastic Large Cell Lymphoma 02/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2016
1	Cytopenia 01/2014
1	Composite Lymphoma 05/2013
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 02/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2012
1	Lymphocytosis 03/2012
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 03/2012
1	Breast Neoplasms (Breast Cancer) 03/2012
1	Disease Progression 04/2011
1	Hairy Cell Leukemia 01/2011
1	Leukocytosis (Pleocytosis) 01/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2011
1	Pathologic Complete Response 01/2010

Drug/Important Bio-Agent (IBA)

9	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2003
6	Proteins (Proteins, Gene)FDA Link 03/2020 - 02/2006
5	Cyclin D1IBA 08/2022 - 08/2006
5	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2018 - 01/2003
4	Anaplastic Lymphoma KinaseIBA 03/2020 - 10/2003
4	CyclinsIBA 01/2020 - 08/2006
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2014 - 02/2006
3	AntigensIBA 03/2020 - 01/2017
3	Cyclin D2IBA 01/2020 - 08/2006
3	T-Cell Intracellular Antigen-1IBA 04/2011 - 01/2002
3	Granzymes (Granzyme)IBA 04/2011 - 01/2002
3	Immunoglobulin D (IgD)IBA 01/2009 - 08/2006
2	5- (benzoylamino)- N- (4- chlorophenyl)- 3- methyl- 4- isothiazolecarboxamide (ITCL)IBA 01/2022 - 10/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2016 - 03/2012
2	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 06/2011
2	ParaffinIBA 08/2011 - 06/2011
2	6-sulfo sialyl Lewis XIBA 07/2010 - 01/2009
2	Messenger RNA (mRNA)IBA 11/2009 - 08/2009
2	Immunoglobulin M (IgM)IBA 01/2009 - 08/2006
2	RNA (Ribonucleic Acid)IBA 08/2007 - 01/2003
1	phytobacteriomycin (PBM)IBA 08/2022
1	InterferonsIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Dasatinib (BMS 354825)FDA Link 11/2020
1	carboxyl radical (COO-)IBA 05/2020
1	interferon regulatory factor-4IBA 03/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Cyclin D3IBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2018
1	Rituximab (Mabthera)FDA Link 12/2018
1	Muramidase (Lysozyme)IBA 09/2018
1	Coloring Agents (Dyes)IBA 09/2018
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Tyrosine (L-Tyrosine)FDA Link 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Keratins (Keratin)IBA 03/2017
1	CarbohydratesIBA 01/2017
1	TNF Receptor-Associated Factor 3IBA 01/2017
1	fascinIBA 07/2016
1	Prednisolone (Predate)FDA LinkGeneric 02/2016
1	Vincristine (Oncovin)FDA LinkGeneric 02/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2016
1	HLA-DR Antigens (HLA-DR)IBA 01/2015
1	MyogeninIBA 01/2014
1	DesminIBA 01/2014
1	ChromatinIBA 03/2012
1	Epirubicin (Ellence)FDA LinkGeneric 03/2012
1	Fluorouracil (Carac)FDA LinkGeneric 03/2012
1	Monoclonal AntibodiesIBA 08/2011
1	Formaldehyde (Formol)FDA Link 06/2011
1	Tartrate-Resistant Acid PhosphataseIBA 01/2011
1	Purine NucleosidesIBA 01/2011
1	Indicators and Reagents (Reagents)IBA 07/2010
1	gamma-delta T-Cell Antigen Receptors (T-Cell Receptor delta-Chain)IBA 07/2010
1	Nuclear Proteins (Protein, Nuclear)IBA 11/2009

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 02/2016 - 01/2002
7	Therapeutics 01/2020 - 04/2003
4	Radiotherapy 02/2016 - 11/2002
1	Adjuvant Chemotherapy 01/2016
1	Combination Drug Therapy (Combination Chemotherapy) 01/2010